Esuprone

TargetMol
Product Code: TAR-T27288
Supplier: TargetMol
CodeSizePrice
TAR-T27288-1mg1mg£185.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27288-1mL1 mL * 10 mM (in DMSO)£343.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27288-5mg5mg£360.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27288-10mg10mg£496.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27288-25mg25mg£760.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27288-50mg50mg£1,018.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27288-100mg100mg£1,348.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27288-500mg500mg£2,633.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Esuprone, a MAO-A inhibitor, is used potentially for the treatment of depression.
CAS:
91406-11-0
Formula:
C13H14O5S
Molecular Weight:
282.31
Pathway:
Metabolism|Neuroscience
Purity:
0.98
SMILES:
CCS(=O)(=O)Oc1ccc2c(C)c(C)c(=O)oc2c1
Target:
MAO

References

1. L?scher W, Lehmann H, Teschendorf HJ, Traut M, Gross G. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy. J Pharmacol Exp Ther. 1999 Mar;288(3):984-92. PubMed PMID: 10027835. 2. Bergstr?m M, Westerberg G, L?ngstr?m B. 11C-harmine as a tracer for monoamine oxidase A (MAO-A): in vitro and in vivo studies. Nucl Med Biol. 1997 May;24(4):287-93. PubMed PMID: 9257326. 3. Bergstr?m M, Westerberg G, N?meth G, Traut M, Gross G, Greger G, M?ller-Peltzer H, Safer A, Eckern?s SA, Grahn?r A, L?ngstr?m B. MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography. Eur J Clin Pharmacol. 1997;52(2):121-8. PubMed PMID: 9174681.